Qualitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV.

Jessica J TuanHeidi ZapataTerese Critch-GilfillanLinda RyallBarbara TurcotteSuzana MuticLaurie AndrewsMichelle E RohGerald FriedlandLydia BarakatOnyema Ogbuagu

Published in: HIV medicine (2021)

Our study suggests that completing a two-dose series of BNT162b2 vaccine is critical for PLWH given suboptimal seroconversion rates after the first dose and subsequent improved seroconversion rates after the second dose.

Keyphrases

sars cov
respiratory syndrome coronavirus
physical activity
clinical evaluation